Sarah Sammons, MD
PeerErica L. Mayer, MD, MPH
PeerHow Do Brain Metastases Affect Your Choice of Systemic Treatment in a Patient with HR+/HER2-low MBC?
Sarah Sammons, MD
PeerErica L. Mayer, MD, MPH
PeerWho Is the Best Candidate for Sequencing Sacituzumab Govitecan Before T-DXd in HR+ Breast Cancer?
Sarah Sammons, MD
PeerIndividualizing Frontline Treatment
Bispecific Antibodies in FL
Antibody-Drug Conjugates in FL
NCCN Guideline Updates in DLBCL